Breaking News
March 22, 2018 - Range of Vaginal Dryness Products Can Help Postmenopausal Women: Study
March 22, 2018 - Higher Dose Tx Deemed Safe in Pulmonary TB
March 22, 2018 - Diet soda associated with higher odds of diabetic retinopathy
March 22, 2018 - LSD reduces ‘sense of self’
March 22, 2018 - Vitamin D deficiency linked to metabolic syndrome in postmenopausal women
March 22, 2018 - Changes in the intestines may be responsible for reversal of diabetes after bariatric surgery
March 22, 2018 - iPads and Cancer; Clot Retrieval and Stroke: It’s PodMed Double T!
March 22, 2018 - Premature births linked to changes in mother’s bacteria
March 22, 2018 - Brain SPECT scans predict treatment outcomes in patients with depression
March 21, 2018 - Researchers succeed in integrating artificial organelles into cells of living organism
March 21, 2018 - Researchers discover ‘missing mutation’ in severe infant epilepsy
March 21, 2018 - Researchers develop statistics-based computational scheme to zoom in on brain function
March 21, 2018 - Verge joins Genomics England’s Discovery Forum industry partnership
March 21, 2018 - Trovagene Announces First Patient Successfully Completes Cycle 1 of Treatment with PCM-075 in Combination with Low Dose Cytarabine (LDAC) in AML Trial
March 21, 2018 - Congenital Cardiac Cath Tx Often Strays from Guidelines
March 21, 2018 - Marked increase in cardiovascular risk factors in women after preeclampsia
March 21, 2018 - New app may help predict, track manic and depressive episodes in bipolar patients
March 21, 2018 - Discovery of genes could lead to development of novel therapies for EBV-related cancers
March 21, 2018 - High-fat, high-cholesterol diet depletes ranks of artery-protecting immune cells
March 21, 2018 - Research misconduct allegations shadow likely CDC appointee
March 21, 2018 - Most Breast Ca Patients Fail to Get Genetic Counseling
March 21, 2018 - Lopsided ear function can lead to lopsided brain development
March 21, 2018 - Acupuncture helps manage menopausal symptoms, review finds
March 21, 2018 - Motor skill training may contribute to reading skills in obese children
March 21, 2018 - Poor dental health may be related to increased diabetes risk
March 21, 2018 - Chronic opioid users at increased risk of complications after spinal fusion surgery
March 21, 2018 - Study uncovers potential therapeutic target against large family of parasites
March 21, 2018 - NSAID use linked to increased risk of atrial fibrillation
March 21, 2018 - Scientists develop brain “stethoscope” that can detect silent seizures
March 21, 2018 - New method predicts effects of global warming on disease
March 21, 2018 - Insurance Company Hurdles Burden Doctors, May Harm Patients
March 21, 2018 - Renal Transplant from HCV-Positive Donors Feasible
March 21, 2018 - Myelodysplastic syndrome: MedlinePlus Medical Encyclopedia
March 21, 2018 - Research reveals brain mechanism involved in language learning
March 21, 2018 - Many parents still hesitate to try early peanut introduction, survey finds
March 21, 2018 - Audiologist urges tinnitus sufferers facing ‘revolving door healthcare’ to seek support
March 21, 2018 - Study reveals impact of prostate cancer on wives and partners of sufferers
March 21, 2018 - ‘Almost a Miracle Drug’: What We Heard This Week
March 21, 2018 - Study shows NIH spent >$100 billion on basic science for new medicines
March 21, 2018 - Columbia researchers identify nerve cells that drive fruit fly’s escape behavior
March 21, 2018 - Sartorius Stedim Biotech selected by ABL Europe to supply single-use process technologies
March 21, 2018 - Increase in coffee consumption may help battle against colon cancer
March 21, 2018 - Hydrogel may accelerate healing of diabetic ulcers
March 21, 2018 - Dermira’s Two Phase 3 Trials Evaluating Olumacostat Glasaretil in Patients with Acne Vulgaris Did Not Meet Co-Primary Endpoints
March 21, 2018 - DePuy Synthes introduces ACTIS Total Hip System for improving initial implant stability
March 21, 2018 - ‘Oh, It Was Nothing’
March 21, 2018 - Herbal drug kratom linked to salmonella illnesses, CDC says
March 21, 2018 - New optical point-of-care device could enhance screening for thyroid nodules
March 21, 2018 - FDA Expands Approval of Adcetris (brentuximab vedotin) for First-Line Treatment of Stage III or IV Classical Hodgkin Lymphoma in Combination with Chemotherapy
March 21, 2018 - Eosinophilic Esophagitis: Late Manifestation of Allergic March
March 21, 2018 - Signaling pathway involving the Golgi apparatus identified in cells with Huntington’s disease
March 21, 2018 - Quintupling inhaled steroid doses may not benefit children with asthma
March 21, 2018 - Study shows clear connection between cardiovascular fitness in middle age and dementia risk
March 21, 2018 - Premature babies have higher risks of health complications in Bangladesh
March 21, 2018 - Child’s temperament and parenting influence weight gain in babies
March 21, 2018 - Researchers find the heart to be capable of arrhythmia termination after local gene therapy
March 21, 2018 - Inhealthcare to provide digital infrastructure for NHS to help protect people from falls
March 21, 2018 - Flu Season Finally Slowing Down
March 21, 2018 - Mixed Results for Shorter DAPT in ACS Patients
March 21, 2018 - Scientists discover fish scale-derived collagen effective for healing wounds
March 21, 2018 - Genomics England announces new partnership to improve efficiency of next-generation sequencing analysis
March 21, 2018 - Adjuvant AC chemotherapy found to be effective in treating HRD-positive breast cancer patients
March 21, 2018 - Researchers identify new treatment targets for lung diseases using big data
March 21, 2018 - Kids see more women in science than five decades ago
March 21, 2018 - Research shows link between chronic fatigue syndrome and lower thyroid hormone levels
March 21, 2018 - Alzheimer’s disease on the rise
March 21, 2018 - Two Agents Equal as Pretreatment for Adrenal Tumor Surgery
March 21, 2018 - ‘Icebreaker’ protein opens genome for T cell development, researchers find
March 21, 2018 - Women in medicine shout #Metoo about sexual harassment at work
March 21, 2018 - Mother’s pre-pregnancy waist size may be linked to child’s autism risk
March 21, 2018 - Second hand marijuana smoke can cause serious damage
March 21, 2018 - International study shows benefits of using MRI at the start of prostate cancer diagnosis
March 20, 2018 - Santhera Reports Outcome of Exploratory Trial with Idebenone in PPMS Conducted at the NIH
March 20, 2018 - ECG Patch Ups At-Home Afib Diagnosis in mSToPS Trial
March 20, 2018 - ROS-scavenging nanozymes for anti-inflammation therapeutics
March 20, 2018 - Genomics England announces appointment of global genomics pioneer as first CEO
March 20, 2018 - Test flight at German Aerospace Center in Cologne demonstrates functionality of deficopter
March 20, 2018 - Music therapy helps treat combat-related psychological injuries in military personnel
March 20, 2018 - Innovative psychotherapeutic treatment protocol for obsessive-compulsive disorders
March 20, 2018 - Weight loss after lap-band surgery alleviates arthritic knee pain
Deadly heart rhythm halted by noninvasive radiation therapy

Deadly heart rhythm halted by noninvasive radiation therapy

image_pdfDownload PDFimage_print
A novel strategy to treat a life-threatening irregular heart rhythm called ventricular tachycardia relies on noninvasive radiation therapy, which is typically directed at cancerous tumors. Noninvasive imaging techniques show irregular heart tissue mapped with the location of misfiring electrical signals, allowing doctors to direct radiation at the specific area of the heart triggering the problem. Pictured is a cross section of a patient’s chest. The problematic heart tissue is highlighted in color. Credit: Clifford Robinson

Radiation therapy often is used to treat cancer patients. Now, doctors at Washington University School of Medicine in St. Louis have shown that radiation therapy—aimed directly at the heart—can be used to treat patients with a life-threatening heart rhythm. They treated five patients who had irregular heart rhythms, called ventricular tachycardia, at the School of Medicine.

The patients had not responded to standard treatments and collectively experienced more than 6,500 episodes of ventricular tachycardia in the three months before they were treated with radiation therapy. In ventricular tachycardia, the heart beats exceedingly fast and its chambers often fall out of sync, interfering with blood flow and placing patients at risk of sudden cardiac death. When delivered directly to problematic areas of the heart muscle, the radiation therapy resulted in a dramatic reduction in the number of ventricular arrhythmia events in these patients, as measured by their implanted defibrillators.

An analysis of the patients’ experiences is reported Dec. 14 in The New England Journal of Medicine. There have been two previous cases reported of treating ventricular tachycardia with radiation therapy, but this is the first to do so in an entirely noninvasive process, from imaging to treatment.

“As a radiation oncologist who specializes in treating lung cancer, I’ve spent most of my career trying to avoid irradiating the heart,” said senior author Clifford G. Robinson, MD, an associate professor of radiation oncology. “But I also have been exploring new uses for stereotactic body radiation therapy that we use almost exclusively for cancer.”

At the same time, cardiologist and first author Phillip S. Cuculich, MD, an associate professor of medicine, was looking for new ways to treat ventricular tachycardia in patients who did not respond to conventional treatments. Ventricular tachycardia is estimated to cause 300,000 deaths per year in the U.S. and is the leading cause of sudden cardiac death. Standard therapy includes medication and invasive procedures that involve threading a catheter through a vein into the heart and selectively burning the tissue that causes the electrical circuits of the heart to misfire.

“These patients have defibrillators implanted to act like a paramedic and save their lives if a bad heart rhythm starts up,” Cuculich said. “The device recognizes a dangerous arrhythmia and can deliver a life-saving electrical shock. While it’s wonderful that we can stop people from dying in that situation, the shock can be a traumatic event. Patients understand that they have just avoided death. And when this happens repetitively, often without warning, it can be devastating for patients.”

A noninvasive cardiac map shows the electrical signals of a single beat. The gray area is a scar from a prior heart attack. The electrical signals that cause ventricular tachycardia enter the scar at the blue area, follow the yellow arrow along the border of the scar and exit the scar at the red area. Credit: Philip Cuculich

Ventricular tachycardia often develops after injury to the heart, commonly following a heart attack. As the heart muscle attempts to heal, the resulting scars interrupt the proper flow of electrical impulses. Traditional catheter ablation essentially kills off the tissue that triggers the electrical misfires. But the procedure is too risky for many patients with additional medical problems, and the arrhythmia often returns after a period of time.

The five patients in the study had undergone catheter ablation procedures and their ventricular tachycardia returned, or they were unable to go through the procedure because of other high-risk medical conditions. One patient was on the waiting list for a heart transplant. Four of the patients were in their 60s; one patient was over age 80.

In the three months before treatment with noninvasive radiation therapy, the five patients together experienced more than 6,500 ventricular tachycardia events. The average number of events per patient during this time was 1,315, with a range of five to 4,312. During the first six weeks following radiation therapy, as the patients were recovering, they experienced a total of 680 episodes. In the one year the patients continued to be followed, they collectively had four events. Two patients didn’t experience any episodes at all. The investigators are cautious, saying they are still monitoring for long-term side effects of radiation therapy, such as lung scarring and further damage to the heart itself. They emphasized that their use of external radiation to the heart only included very ill patients in end-stage disease who had run out of options. More research is required before doctors might consider this approach for younger, healthier patients or as a possible addition to standard therapies.

“A lot of my work is focused on reducing toxicity of radiation therapy using modern technology,” Robinson said. “These patients have done quite well in the first 12 months after therapy, which is enough time to see the early toxicities. But we’re continuing to monitor patients for long-term side effects.”

The single dose of radiation these patients received is on par with what might be given to a patient with an early-stage lung tumor. Doctors can target such tumors with a large dose of radiation given once or up to five times.

The preparation and mapping of the anatomy and electrical circuits of the heart is time-intensive, but the treatment itself takes 10-15 minutes, the researchers said.

Credit: Washington University BioMed Radio

“A traditional catheter ablation procedure can take six hours or more and requires general anesthesia,” Cuculich said. “This new process is entirely noninvasive. We take pictures of the heart with various imaging methods—MRI, CT, PET scans. But the unique piece is the noninvasive electrical mapping called electrocardiographic imaging. This allows us to pinpoint where the arrhythmias are coming from. When we overlay the scar mapping with the electrical mapping, we get a beautiful model of heart function that lets us see not only where the arrhythmia comes from, but where it might progress.

“Based on these maps, Dr. Robinson is then able to deliver the energy entirely noninvasively,” Cuculich added. “It’s simply amazing to see a ventricular tachycardia patient get an ablation therapy for a few minutes and then get up off the table and walk out the door.”

Electrocardiographic imaging (ECGI) was developed by co-author and Washington University biomedical engineer Yoram Rudy, PhD, the Fred Saigh Distinguished Professor of Engineering.

The radiation therapy does not take effect immediately. The number of arrhythmia events went down but did not disappear in the first six weeks after treatment, which the doctors characterize as a recovery period. After that six-week period, however, the number of events dropped to almost zero. Patients were able to slowly come off medications used to control the arrhythmia.

Of the five patients, one patient died in the first month after treatment of causes unlikely to be related to treatment. This patient, who was over age 80, had other heart conditions in addition to ventricular tachycardia. The remaining four, who are all in their 60s, are alive two years after radiation therapy. The patient on the transplant list went on to receive a new heart. One whose arrhythmia continues to be controlled also is dealing with gradual heart failure, meaning the heart muscle is weakening over time, and has received a left ventricular assist device. Two patients continue to live unassisted without ventricular tachycardia.

The researchers currently are enrolling patients in a clinical trial to further evaluate this approach and, to date, have performed the procedure on 23 patients.

Explore further:
Study finds catheter ablation is a better treatment for recurrent ventricular tachycardia

Journal reference:
New England Journal of Medicine

Provided by:
Washington University School of Medicine

Tagged with:

About author

Related Articles